Apocynin: A potent NADPH oxidase inhibitor for the management of atrial fibrillation

Redox Report

Volumn 13, Issue 6, 2008, Pages 242-245

  Sovari, Ali A ^a   Morita, Norishige ^a   Karagueuzian, Hrayr S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apocynin; Atrial fibrillation; Oxidative stress

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOCYNIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CAUSAL ATTRIBUTION; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENZYME INHIBITION; HEART ATRIUM FIBRILLATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECURRENT DISEASE;

ACETOPHENONES; ANTIOXIDANTS; ATRIAL FIBRILLATION; MODELS, THEORETICAL; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 58049213896     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100008X309000     Document Type: Article

References (37)

1. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data. J Am Coll Cardiol 2007; 50: 2021-2028
2. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530-1535
3. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006; 108: 346-353.
4. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 2007; 101: 755-758.
5. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986; 58: 356-371.
6. Neuman RB, Bloom HL, Shukrullah I et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007; 53: 1652-1657.
7. Beresewicz A, Horackova M. Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: Possible ionic mechanisms. J Mol Cell Cardiol 1991; 23: 899-918.
8. Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006; 318: 214-222.
9. Thomas GP, Sims SM, Cook MA, Karmazyn M. Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J Pharmacol Exp Ther 1998; 286: 1208-1214.
10. 2+ exchanger activation by hydrogen peroxide in guinea-pig ventricular myocytes. J Pharmacol Sci 2007; 103: 283-292.
11. Morris TE, Sulakhe PV. Sarcoplasmic reticulum Ca(2+)-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic Biol Med 1997; 22: 37-47.
12. Anzai K, Ogawa K, Kuniyasu A, Ozawa T, Yamamoto H, Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Commun 1998; 249: 938-942.
13. Ono N, Hayashi H, Kawase A et al. Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. Am J Physiol 2007; 292: H639-H648.
14. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659-665.
15. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461-2468.
16. Morel F, Doussers J, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem 1991; 201: 523-546.
17. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-285.
18. Kabe Y, Ando K, Hirao S et al. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antiox Redox Signal 2005; 7: 395-403.
19. Lu L, Chen SS, Zhang JQ et al. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem Biophys Res Commun 2004; 321: 879-885.
20. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007; 93: 903-907.
21. Williams HC, Griendling KK. NADPH oxidase inhibitors: New antihypertensive agents? J Cardiovasc Pharmacol 2007; 50: 9-16.
22. Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 2003; 35: 851-859.
23. Sun Y. Oxidative stress and cardiac repair/remodeling following infarction. Am J Med Sci 2007; 334: 197-205.
24. Dudley Jr SC, Hoch NE, McCann LF et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation 2005; 112: 1266-1273.
25. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 68-74.
26. Shah DC, Haïssaguerre M, Jaïs P. Catheter ablation of pulmonary vein foci for atrial fibrillation: PV foci ablation for atrial fibrillation. Thorac Cardiovasc Surg 1999; 47 (Suppl 3): 352-356.
27. phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007; 100; 894-903.
28. Maggioni AP, Latini R, Carson PE et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart ailure: Results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005; 149: 548-557.
29. Wachtell K, Lehto M, Gerdts E et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712-719.
30. Stolk J, Hiltermann JTN, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin a methoxy substituted catechol. Am J Respir Cell Mol Biol 1994; 11: 95-102.
31. Engels F, Renirie BF, 't Hart BA, Labadie RP, Nijkamp FP. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 1992; 305: 254-256.
32. Qin F, Simeone M, Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic Biol Med 2007; 43: 271-281.
33. Park YM, Park MY, Suh YL, Park JB. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 2004; 313: 812-817.
34. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidase derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol 2008 July 3 [Epub ahead of print].
35. Virdis A, Neves MF, Amiri F et al. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004; 22: 535-542.
36. Holland JA, Johnson DK. Prevention of atherosclerosis using NADPH oxidase inhibitors. United States Patent, Patent Number: 5,902,831; 1999.
37. Gajewska R, Ganowiak Z, Grzybowski J, Radecki A, Wrzesniowska K. Analysis of an industrial smoke preparation. Bromat Chem Toksykol 1981; XIV: 3-4.